Mito 40mg Injection
Marketer
Neon Laboratories Ltd
Salt Composition
Mitomycin (40mg)
Overview Mito 40mg Injection
Pancreatic, breast, lung, and gastric cancers may be treated with the 40mg Mito Injection. Administered intravenously under medical supervision, it's employed either solo or within combination chemotherapy regimens. Its mechanism involves disrupting cancerous cell proliferation, leading to their demise. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper use or overdose can trigger severe adverse effects. While benefits might not be immediately apparent (weeks or months may pass), discontinue use only under your doctor's instruction. Common side effects include anemia, leukopenia, increased bleeding risk, anorexia, nausea, and vomiting; report any concerning symptoms. Prior to commencing treatment, disclose any pre-existing blood, kidney, liver, or respiratory conditions. Mito Injection lowers blood cell counts, elevating infection susceptibility; therefore, regular blood tests monitoring blood cell levels, along with kidney, liver, and cardiac function are mandatory. Effective contraception is essential for both partners during treatment to prevent pregnancy.
Uses of Mito 40mg Injection
Malignancies of the pancreas, breast, lung (non-small cell), and stomach.
Major Benefits of Mito 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mito 40mg Injection:
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Increased bleeding tendency
- Loss of appetite
- Nausea
- Vomiting
- Feeling of discomfort
- Low blood platelets
- Weight loss
- Rash
How to use Mito 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mito 40mg Injection works:
The anticancer drug, Mito 40mg Injection, inhibits cancer cell proliferation by targeting and disrupting their DNA, thus halting their growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mito 40mg Injection and alcohol can lead to significant sleepiness.
PregnancyUNSAFE
Administration of Mito 40mg Injection is contraindicated during pregnancy. Pregnant individuals should consult their physician; research in animal and human subjects reveals substantial adverse effects on fetal development.
Breast feedingCAUTION
Administering Mito 40mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administering Mito 40mg Injection may induce adverse reactions, potentially impacting driving capabilities. Nausea and vomiting, possible side effects of Mito 40mg Injection, can significantly decrease reaction time, compromising safe operation of a motor vehicle.
KidneyCAUTION
Exercise caution when administering Mito 40mg Injection to individuals with impaired kidney function; dosage modification may be necessary. Physician consultation is advised. Mito 40mg Injection is contraindicated in patients exhibiting end-stage renal disease.
LiverCAUTION
Administering Mito 40mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification of Mito 40mg Injection might be necessary. Physician consultation is advised. Mito 40mg Injection may be contraindicated for certain patients exhibiting liver dysfunction.
What if you forget to take Mito 40mg Injection :
NA
Facts to Know About Mito 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Cancer-Fighting Antibiotics |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently